Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for M0224. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
14
Median % of Medicare
--
Rate range
$303.75 - $472.50
M0224 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Arkansas | $450.00 | -- | -- | 2026 |
| California | $450.00 | -- | -- | 2026 |
| District of Columbia | $401.04 | -- | Not required | 2026 |
| Hawaii | $472.50 | -- | -- | 2025 |
| Indiana | $424.35 | -- | -- | 2024 |
| Maryland | $450.00 | -- | -- | 2024 |
| Maine | $308.86 | -- | -- | 2026 |
| Missouri | $303.75 | -- | Not required | 2024 |
| Mississippi | $450.50 | -- | -- | 2024 |
| North Dakota | $441.00 | -- | Not required | 2026 |
| New Hampshire | $450.00 | -- | Not required | 2026 |
| New Mexico | $450.00 | -- | -- | 2024 |
| Pennsylvania | $360.00 | -- | -- | 2024 |
| Utah | $348.61* | -- | Not required | 2024 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 4 codes from M0201 to M0250 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for M0224?
14 state Medicaid programs publish a fee-for-service rate for M0224 (intravenous infusion, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, includes infusion and post administration monitoring), ranging from $303.75 in Missouri to $472.50 in Hawaii. The full table on this page lists every publishing state's current rate.
Which state pays the most for M0224?
Hawaii publishes the highest Medicaid rate for M0224 at $472.50. Missouri publishes the lowest at $303.75.
Does M0224 require prior authorization under Medicaid?
No publishing state flags M0224 with a prior-authorization indicator on its fee schedule. Absence of a flag means the state publishes none, not that PA is never required - confirm through the state's provider manual.